These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 770106)
1. The objective and timing of drug disposition studies. Weiner M Drug Metab Rev; 1975; 4(2):229-39. PubMed ID: 770106 [No Abstract] [Full Text] [Related]
2. [First-pass effect as a therapeutic problem]. Danek A Pol Tyg Lek; 1983 Apr; 38(16):511-4. PubMed ID: 6634498 [No Abstract] [Full Text] [Related]
3. [Metabolism of drugs and drug security]. Rentsch GA Dtsch Med Wochenschr; 1975 Oct; 100(44):2285-92. PubMed ID: 1183328 [No Abstract] [Full Text] [Related]
4. Methods for estimating drug bioavailability parameters. Part 1: Concept of biological availability and methods for estimating the extent of systemic absorption. Firsov AA; Piotrovskii VK Pharmazie; 1986 May; 41(5):313-9. PubMed ID: 3737660 [No Abstract] [Full Text] [Related]
6. A stable method for calculating oral drug absorption rate constants with two compartment disposition. Saunders L; Natunen T J Pharm Pharmacol; 1973 Dec; 25():Suppl:44P-51P. PubMed ID: 4150591 [No Abstract] [Full Text] [Related]
7. Bioequivalence of drug products. Koritz GD J Am Vet Med Assoc; 1980 Aug; 177(3):279-81. PubMed ID: 7440334 [No Abstract] [Full Text] [Related]
8. Methods for estimating drug bioavailability parameters. Part 2: Methods for estimating absorption rate. Firsov AA; Piotrovskii VK Pharmazie; 1986 Jun; 41(6):369-77. PubMed ID: 3763679 [No Abstract] [Full Text] [Related]
9. Intestinal drug absorption and bioavailability: beyond involvement of single transport function. Lennernäs H J Pharm Pharmacol; 2003 Apr; 55(4):429-33. PubMed ID: 12803763 [No Abstract] [Full Text] [Related]
10. Methods for estimating drug bioavailability parameters. Part 3: Peculiarities of pharmacokinetic analysis in assessment of bioavailability. Firsov AA; Piotrovskii VK Pharmazie; 1986 Jul; 41(7):457-65. PubMed ID: 3534896 [No Abstract] [Full Text] [Related]
11. Gastrointestinal absorption II. Formulation factors affecting drug bioavailability. Blanchard J Am J Pharm Sci Support Public Health; 1978; 150(5):132-51. PubMed ID: 364993 [No Abstract] [Full Text] [Related]
12. Scientific commentary. Drug absorption and disposition as monitors of safety and efficacy. Cabana BE; Dittert LW J Pharmacokinet Biopharm; 1975 Apr; 3(2):143-58. PubMed ID: 1151616 [No Abstract] [Full Text] [Related]
13. [Effects of drug distribution, entero-hepatic cycle, bioavailability]. Bailly-Salins F; Woronoff-Lemsi MC Soins; 1998 Apr; (624):41-3. PubMed ID: 9633463 [No Abstract] [Full Text] [Related]
15. [Effect of nutrition on drug bioavailability]. Boutin-Pannetier MS; Delhotal-Landes B; Flouvat B Therapie; 1986; 41(5):397-402. PubMed ID: 3544322 [No Abstract] [Full Text] [Related]
16. Cell culture-based models for intestinal permeability: a critique. Balimane PV; Chong S Drug Discov Today; 2005 Mar; 10(5):335-43. PubMed ID: 15749282 [TBL] [Abstract][Full Text] [Related]
17. [Before or after meals?]. Segarra Domenech J; Santafé Oroz J Med Clin (Barc); 1981 Jul; 77(3):124-9. PubMed ID: 7278423 [No Abstract] [Full Text] [Related]
18. Kinetic implications of drug resorption from the bladder. Wood JH; Leonard TW Drug Metab Rev; 1983; 14(3):407-23. PubMed ID: 6347592 [No Abstract] [Full Text] [Related]